Oncology payment reform and drug reimbursement in the proper perspective

J Oncol Pract. 2015 May;11(3):262. doi: 10.1200/JOP.2014.003418. Epub 2015 Mar 3.

Authors

Mark Thompson¹, Jeffrey Vacirca², Ted Okon³

Affiliations

¹ Mark H. Zangmeister Center, Columbus, OH.
² North Shore Hematology Oncology, East Setauket, NY.
³ Community Oncology Alliance, Virginia Beach, VA tokon@COAcancer.org.

PMID: 25736382
DOI: 10.1200/JOP.2014.003418

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents / economics*
Humans
Neoplasms / economics*

Substances

Antineoplastic Agents